Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis

Matthew L. Meizlish, George Goshua, Yiwen Liu, Rebecca Fine, Kejal Amin, Eric Chang, Nicholas DeFilippo, Craig Keating, Yuxin Liu, Michael Mankbadi, Dayna McManus, Stephen Wang, Christina Price, Robert D. Bona, Cassius Iyad Ochoa Chaar, Hyung J. Chun, Alexander B. Pine, Henry M. Rinder, Jonathan Siner, Donna S. Neuberg, Kent A. Owusu, Alfred Ian Lee
doi: https://doi.org/10.1101/2021.01.12.21249577
Matthew L. Meizlish
1Yale School of Medicine, New Haven, CT
M.Phil.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Goshua
2Section of Hematology, Department of Medicine, Yale School of Medicine, New Haven, CT
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yiwen Liu
3Dana-Farber Cancer Institute, Boston, MA
M.S.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca Fine
4Department of Medicine, Yale School of Medicine, New Haven, CT
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kejal Amin
5Department of Pharmacy, Yale-New Haven Hospital, New Haven, CT
Pharm.D., M.B.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Chang
2Section of Hematology, Department of Medicine, Yale School of Medicine, New Haven, CT
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas DeFilippo
5Department of Pharmacy, Yale-New Haven Hospital, New Haven, CT
6School of Pharmacy, University of Connecticut, Storrs, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Craig Keating
7Joint Data Analytics Team, Yale New Haven Hospital, New Haven, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuxin Liu
2Section of Hematology, Department of Medicine, Yale School of Medicine, New Haven, CT
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Mankbadi
4Department of Medicine, Yale School of Medicine, New Haven, CT
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dayna McManus
5Department of Pharmacy, Yale-New Haven Hospital, New Haven, CT
Pharm.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Wang
4Department of Medicine, Yale School of Medicine, New Haven, CT
M.D., M.P.H.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina Price
8Section of Allergy and Immunology, Department of Medicine, Yale School of Medicine, New Haven, CT
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert D. Bona
2Section of Hematology, Department of Medicine, Yale School of Medicine, New Haven, CT
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cassius Iyad Ochoa Chaar
9Section of Vascular Surgery, Department of Surgery, Yale School of Medicine, New Haven, CT
M.D., M.S.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hyung J. Chun
10Section of Cardiology, Department of Medicine, Yale School of Medicine, New Haven, CT
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander B. Pine
2Section of Hematology, Department of Medicine, Yale School of Medicine, New Haven, CT
M.D., Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henry M. Rinder
2Section of Hematology, Department of Medicine, Yale School of Medicine, New Haven, CT
11Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Siner
12Section of Pulmonary and Sleep Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donna S. Neuberg
3Dana-Farber Cancer Institute, Boston, MA
Sc.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: alfred.lee{at}yale.edu kent.owusu{at}ynhh.org neuberg{at}ds.dfci.harvard.edu
Kent A. Owusu
5Department of Pharmacy, Yale-New Haven Hospital, New Haven, CT
13Clinical Redesign, Yale New Haven Health, New Haven, CT
Pharm.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: alfred.lee{at}yale.edu kent.owusu{at}ynhh.org neuberg{at}ds.dfci.harvard.edu
Alfred Ian Lee
2Section of Hematology, Department of Medicine, Yale School of Medicine, New Haven, CT
M.D., Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: alfred.lee{at}yale.edu kent.owusu{at}ynhh.org neuberg{at}ds.dfci.harvard.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Thrombotic complications occur at high rates in hospitalized patients with COVID-19, yet the impact of intensive antithrombotic therapy on mortality is uncertain.

Research Question How does in-hospital mortality compare with intermediate-versus prophylactic-dose anticoagulation, and separately with in-hospital aspirin versus no antiplatelet therapy, in treatment of COVID-19?

Study Design and Methods Using data from 2785 hospitalized adult COVID-19 patients, we established two separate, nested cohorts of patients (1) who received intermediate- or prophylactic-dose anticoagulation (“anticoagulation cohort”, N = 1624), or (2) who were not on home antiplatelet therapy and received either in-hospital aspirin or no antiplatelet therapy (“aspirin cohort”, N = 1956). Propensity score matching utilizing various markers of illness severity and other patient-specific covariates yielded treatment groups with well-balanced covariates in each cohort. The primary outcome was cumulative incidence of in-hospital death.

Results Among propensity score-matched patients in the anticoagulation cohort (N = 382), in a multivariable regression model, intermediate-compared to prophylactic-dose anticoagulation was associated with a significantly lower cumulative incidence of in-hospital death (hazard ratio 0.518 [0.308-0.872]). Among propensity-score matched patients in the aspirin cohort (N = 638), in a multivariable regression model, in-hospital aspirin compared to no antiplatelet therapy was associated with a significantly lower cumulative incidence of in-hospital death (hazard ratio 0.522 [0.336-0.812]).

Interpretation In this propensity score-matched, observational study of COVID-19, intermediate-dose anticoagulation and aspirin were each associated with a lower cumulative incidence of in-hospital death.

Summary conflict of interest statements No conflict of interest exists for any author on this manuscript.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by a gift donation from Jack Levin and a separate anonymous donation to the Benign Hematology program at Yale, the DeLuca Foundation to fund hematology research at Yale, and the National Institutes of Health (grant HL142818 to H.J.C., and GM136651 and HL139116 to M.L.M.).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the Yale Institutional Review Board (HIC 2000027792). An additional, approved Data Use Agreement between Yale and Dana-Farber Cancer Institute permitted analysis.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All authors have access to the data provided in this manuscript.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted January 15, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis
Matthew L. Meizlish, George Goshua, Yiwen Liu, Rebecca Fine, Kejal Amin, Eric Chang, Nicholas DeFilippo, Craig Keating, Yuxin Liu, Michael Mankbadi, Dayna McManus, Stephen Wang, Christina Price, Robert D. Bona, Cassius Iyad Ochoa Chaar, Hyung J. Chun, Alexander B. Pine, Henry M. Rinder, Jonathan Siner, Donna S. Neuberg, Kent A. Owusu, Alfred Ian Lee
medRxiv 2021.01.12.21249577; doi: https://doi.org/10.1101/2021.01.12.21249577
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis
Matthew L. Meizlish, George Goshua, Yiwen Liu, Rebecca Fine, Kejal Amin, Eric Chang, Nicholas DeFilippo, Craig Keating, Yuxin Liu, Michael Mankbadi, Dayna McManus, Stephen Wang, Christina Price, Robert D. Bona, Cassius Iyad Ochoa Chaar, Hyung J. Chun, Alexander B. Pine, Henry M. Rinder, Jonathan Siner, Donna S. Neuberg, Kent A. Owusu, Alfred Ian Lee
medRxiv 2021.01.12.21249577; doi: https://doi.org/10.1101/2021.01.12.21249577

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Hematology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)